January 17, 2025

FDA Chief Warns of Online Drug Risks

Outgoing FDA Commissioner raises concerns about safety of online-purchased compounded weight loss meds, highlighting challenges faced by the FDA, amidst contrasting views from nominee for Health and Human Services Secretary.

Reuters

January 17, 2025

Trial: High-Dose Semaglutide Cuts Weight 20.7%

Novo Nordisk's high-dose semaglutide trial demonstrates a 20.7% weight reduction in overweight patients with obesity, promising new advancements in the treatment of obesity and diabetes.

Reuters

January 16, 2025

FDA Clears Phase 2 Trial: Lorundrostat for OSA-Hypertension

Mineralys Therapeutics receives FDA clearance for a phase II clinical trial investigating lorundrostat, an aldosterone synthase inhibitor, in patients with moderate-to-severe obstructive sleep apnea and hypertension.

Conexiant

January 15, 2025

FDA to Revoke Red No. 3

Red No. 3 is found in many popular food items, including Pop Tarts, Dole Fruit Packs, Double Bubble Gum, Peeps, and more.

Conexiant

January 15, 2025

Bertagnolli to Exit NIH Director Role

NIH director, Dr. Monica M. Bertagnolli, is stepping down after launching major initiatives in women's health and long COVID research, indicating optimism for their continuation under new leadership.

Conexiant

January 14, 2025

FDA Pushes Front-of-Pack Nutrition Labels

The FDA has proposed a new front-of-package nutrition label for packaged foods, in line with broader efforts to address the nation's chronic disease crisis. The World Health Organization has also advocated for easily accessible nutritional information to support healthier choices.

Reuters

January 09, 2025

Medicare Covers Tirzepatide for Sleep Apnea

Eli Lilly's tirzepatide gets Medicare coverage for sleep apnea, widening access to weight-loss treatment. Are obesity drugs getting a breakthrough?

Reuters

January 08, 2025

Novo Boosts AI Partnership for Obesity Drugs

Novo Nordisk and Valo Health are expanding their partnership to develop new treatments for cardiometabolic diseases, focusing on obesity, type 2 diabetes, and cardiovascular diseases, with significant financial commitments and intense market competition.

Reuters

January 03, 2025

Surgeon General Issues Advisory on Alcohol, Cancer Link

Of all breast cancer cases in the U.S., 16.4% are directly linked to alcohol consumption.

Conexiant